Zaffre Investments: Funding, Team & Investors

Zaffre Investments operates as a venture capital and private equity arm, channeling capital into healthcare innovation. The firm strategically invests in solutions designed to improve healthcare delivery and enhance the consumer experience. It targets companies developing technologies and services that provide tangible impact across the healthcare value chain.

Established in 2014, Zaffre Investments was formed as a wholly-owned subsidiary of Blue Cross Blue Shield of Massachusetts, Inc. The parent company recognized a strategic imperative to invest in emerging healthcare solutions, aiming to address evolving consumer demands and propel industry advancement. This initiative reflects a commitment to fostering transformative ventures.

Zaffre Investments' portfolio companies cater to diverse healthcare consumers, striving to make services more accessible, efficient, and user-friendly. The firm's long-term vision is to actively shape the future of healthcare by supporting entrepreneurial efforts aligned with its mission of delivering superior outcomes and cultivating an ecosystem of innovative solutions.

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 11, 2018	InfoBionic	$50.0M Other Equity	—	Blue Cross And Blue Shield OF Kansas, Eagle Proprietary Investments, Excel Venture Management, Safeguard Scientifics
Apr 1, 2018	Teladoc Health	$110.0M Series E	General Catalyst, Georgi Ganev	7wire Ventures, Andreessen Horowitz, Broadway Angels, Celesta, Define Ventures, Element Partners, First Round Capital, Founders Circle Capital, Fuel Capital, Index Ventures, Koch Fund, Lightbank, Lobby Capital, LUX Capital, Meritech Capital Partners, Montage Ventures, Sapphire Ventures, SciFi VC, Theory Ventures, Threshold Ventures, Valar Ventures, Yobe Ventures, Zinc, Errol Damelin, Leah Busque, RIC Fulop, Richard Branson, Robin Klein, Roger Ehrenberg, SUE XU, DFJ, Echo Health Ventures, Kleiner Perkins, M12, Merck
Nov 1, 2016	Cohero Health	$13.0M Series A	Sean Kearney	BioAdvance, GIS Strategic Ventures, Heitkamp & Thumann Group, P5 Health Ventures
Dec 1, 2015	Cohero Health	$2.0M Seed	—	BioAdvance, Foundry Group, Fusion Fund, Plug & Play Ventures, Eric Ries, Jaffray Woodriff, StartUp Health, Swanhill Capital, Three Leaf Ventures
Aug 5, 2015	InfoBionic	$8.0M Series B	Safeguard Scientifics	Excel Venture Management

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 11, 2018	InfoBionic	$50.0M Other Equity	—	Blue Cross And Blue Shield OF Kansas, Eagle Proprietary Investments, Excel Venture Management, Safeguard Scientifics
Apr 1, 2018	Teladoc Health	$110.0M Series E	General Catalyst, Georgi Ganev	7wire Ventures, Andreessen Horowitz, Broadway Angels, Celesta, Define Ventures, Element Partners, First Round Capital, Founders Circle Capital, Fuel Capital, Index Ventures, Koch Fund, Lightbank, Lobby Capital, LUX Capital, Meritech Capital Partners, Montage Ventures, Sapphire Ventures, SciFi VC, Theory Ventures, Threshold Ventures, Valar Ventures, Yobe Ventures, Zinc, Errol Damelin, Leah Busque, RIC Fulop, Richard Branson, Robin Klein, Roger Ehrenberg, SUE XU, DFJ, Echo Health Ventures, Kleiner Perkins, M12, Merck
Nov 1, 2016	Cohero Health	$13.0M Series A	Sean Kearney	BioAdvance, GIS Strategic Ventures, Heitkamp & Thumann Group, P5 Health Ventures
Dec 1, 2015	Cohero Health	$2.0M Seed	—	BioAdvance, Foundry Group, Fusion Fund, Plug & Play Ventures, Eric Ries, Jaffray Woodriff, StartUp Health, Swanhill Capital, Three Leaf Ventures
Aug 5, 2015	InfoBionic	$8.0M Series B	Safeguard Scientifics	Excel Venture Management

Zaffre Investments

Subscribe, Save or Share

About

Investment Activity

Investments Made

Financial History

Investment Activity

Investments Made